The 100% remission rate (CR/CRi) achieved at the highest dose level of the RAINIER trial to date demonstrates mipletamig's potential to redefine the frontline treatment landscape for newly diagnosed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback